# A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer

> **NCT03245203** · NA · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** FOLFIRI+beacizumab
- **PROCEDURE:** CRT

## Key facts

- **NCT ID:** NCT03245203
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03245203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03245203, "A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03245203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*